<DOC>
	<DOCNO>NCT01024400</DOCNO>
	<brief_summary>The purpose study evaluate immunogenicity safety inactivate , non adjuvanted A ( H1N1 ) v influenza vaccine 120 pregnant woman . Study procedures include 2 dos vaccine , blood sample , cord blood sample delivery record temperature vaccine side effect memory aid 7 day follow vaccination . Participants involve study related procedure 3 5 month .</brief_summary>
	<brief_title>Immunogenicity Safety Inactivated Non-adjuvanted A ( H1N1 ) v Influenza Vaccine Pregnant Women</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>18 year 45 year Pregnancy 22 32 week gestation Provides write informed consent Covered French Social Security Allergy eggs component vaccine History severe reaction follow previous influenza vaccine H1N1 influenza ( virologically document ) last 6 month Febrile episode within one week prior vaccination Known HIV , HBV , HCV infection Multiple sclerosis History GuillainBarr√© syndrome Organ transplant recipient Neoplastic disease past 3 year Other vaccine within 3 week prior study entry plan within month follow last injection Systemic corticosteroid , immunotherapy , chemotherapy Anticoagulant treatment Immunoglobulin blood transfusion within 3 month prior enrollment study History cardiac disease Chronic liver disease Diabetes pregnancy History premature delivery History eclampsia Fetal morphologic abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Pregnancy</keyword>
</DOC>